Cancer Cell

SJR Rank #7H-index: 436SJR: 26.632Best quartile: Q1APC: US$10,400
Journal website: aims, scope and author guidelines
Publisher

Cell Press

Country

United States

Type

journal

SJR by Edition

2022202507142128

Subject Categories

  • Cancer ResearchQ1
  • Cell BiologyQ1
  • OncologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer Immunotherapy and BiomarkersEpigenetics and DNA MethylationCancer Genomics and DiagnosticsCancer-related Molecular PathwaysCAR-T cell therapy researchCancer, Hypoxia, and MetabolismImmunotherapy and Immune ResponsesCancer Cells and MetastasisImmune cells in cancerUbiquitin and proteasome pathways

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025055110165220

Detailed Information

ISSN

1535-6108, 1878-3686

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

34.25

References per Document

60.06

Coverage

2002-2026

Scope

Cancer Cell provides a high-profile forum to promote major advances in cancer research and oncology. The primary criterion for considering manuscripts is whether the studies provide major advances into answering important questions relevant to naturally occurring cancers. Cancer Cell particularly welcomes translational research. Cancer Cell is also interested in publishing clinical investigations, in particular those that lead to establishing new paradigms in the treatment, diagnosis, or prevention of cancers; those that provide important insights into cancer biology beyond what has been revealed by preclinical studies; and those that are mechanism-based proof-of-principle clinical studies.

Metrics from SCImago Journal Rank 2025. View on SCImago